| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/17/2003 | WO2003031600A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel |
| 04/17/2003 | WO2003031599A2 Live attenuated salmonella strains for producing vaccines |
| 04/17/2003 | WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 04/17/2003 | WO2003031596A2 Production of a highly active, soluble form of the cytochrome p450 reductase (cpr a) from candida tropicalis |
| 04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | WO2003031589A2 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031579A2 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor |
| 04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
| 04/17/2003 | WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | WO2003031570A2 Method for cloning and expression of bseri restriction endonuclease and bseri methylase in e. coli |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031560A1 Methods, processes and wort compositions related to vicinal diketone evolution and especially diacetyl formation in brewing |
| 04/17/2003 | WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation |
| 04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031014A1 Separation medium, its preparation and its use |
| 04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
| 04/17/2003 | WO2003030824A2 Methods and compositions for treating dermal lesions |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002074965A3 Characterization of the i-spoml endonuclease from fission yeast |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002068468A3 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 04/17/2003 | WO2002061070A3 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/17/2003 | WO2002057664A3 Bacillus thuringiensis insecticidal proteins |
| 04/17/2003 | WO2002055709A3 Rhodococcus cloning and expression vectors |
| 04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
| 04/17/2003 | WO2002050284A3 Oxidoreductases |
| 04/17/2003 | WO2002033094A1 Antibody inhibiting vplf activity |
| 04/17/2003 | WO2002030974A3 Proteins and nucleic acids encoding same |
| 04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
| 04/17/2003 | WO2002028900A3 Tach: new tnf-receptor family nucleic acids and polypeptides |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
| 04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 04/17/2003 | WO2002008400A3 25233, a human aminotransferase and uses therefor |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO2002000721A3 Cytokine receptor zcytor17 |
| 04/17/2003 | WO2001098366A3 Enterokinase cleavage sequences and their use |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | US20030074698 Method for modifying plant morphology, biochemistry and physiology |
| 04/17/2003 | US20030074688 Compositions and methods for the production of betaine lipids |
| 04/17/2003 | US20030074684 Control of gene expression |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073824 DNA encoding methymycin and pikromycin |
| 04/17/2003 | US20030073822 Blood group antigen fusion polypeptides and method of use thereof |
| 04/17/2003 | US20030073821 Antibody for use in human therapeutics and diagnostics |
| 04/17/2003 | US20030073819 PGC-1, a novel brown fat PPARgamma coactivator |
| 04/17/2003 | US20030073621 Antidiabetic agents; isolated nucleic acid; genetic engineering |
| 04/17/2003 | US20030073224 Ketogulonigenium endogenous plasmids |
| 04/17/2003 | US20030073222 Multiply-substituted protease variants |
| 04/17/2003 | US20030073221 Hyaluronan synthase gene and uses thereof |
| 04/17/2003 | US20030073208 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 04/17/2003 | US20030073205 Production of polyketides |
| 04/17/2003 | US20030073204 Process for the manufacture of D-pantothene acid and/or its salts by fermentation |
| 04/17/2003 | US20030073200 Generation of preferential polypeptide in cells; obtain cells, transfrom with vector coding preferential polypeptide, culture, express vector, recover polypeptides |
| 04/17/2003 | US20030073198 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of glandular disorders |
| 04/17/2003 | US20030073187 Nucleotide sequences coding polypeptide for use in treatment and prevention of infection, induction of shock and inflammatory disease |
| 04/17/2003 | US20030073168 Polypeptide for use in the diagnosis, treatment and prevention of cardiovascular diseases |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030073164 Prokaryotically produced antibodies and uses thereof |
| 04/17/2003 | US20030073163 Libraries of expressible gene sequences |
| 04/17/2003 | US20030073161 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and immunological disorders |
| 04/17/2003 | US20030073154 Therapeutic agents that inhibit the TUP1 pathway |
| 04/17/2003 | US20030073144 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 04/17/2003 | US20030073140 Detection of preferential nucleotide sequences in sample; obtain cell, incubate with nucleotide sequences, transform cells, express sequences, detect protein product, presence of protein product indicates presence of nucleotide sequences |
| 04/17/2003 | US20030073137 Periostin-based diagnostic assays |
| 04/17/2003 | US20030073135 Isolating nucleotide sequences coding preferential enzymatic polypeptide; obtain sample sequences, insert in vector and generate library, transorm cells, detect transformants expressing enzymatic polypeptide |
| 04/17/2003 | US20030073109 Isolation of microorganism expressing preferential gene; obtain nucleotide sequences, mutate, insert into vector, transform bacteria, express polypeptide in vector, recover bacteria expressing polypeptide |
| 04/17/2003 | US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030073072 Chimeric adenoviruses |
| 04/17/2003 | US20030073042 Process and materials for formation of patterned films of functional materials |
| 04/17/2003 | US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072765 For therapy and prophylaxis of bacterial infections |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | US20030072726 Phenolic compounds from natural biological materials such as plant material |
| 04/17/2003 | US20030070351 Method for culturing a basidiomycetous fungus in a liquid culture medium |
| 04/17/2003 | DE20207697U1 Yeast supply system comprises a sensor for measuring the alcohol content in a pumping line |
| 04/17/2003 | CA2463453A1 Methods of preparing a targeting vector and uses thereof |
| 04/17/2003 | CA2463093A1 Separation medium, its preparation and its use |
| 04/17/2003 | CA2462873A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | CA2462291A1 Methods and compositions for treating dermal lesions |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2461655A1 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2461429A1 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2461266A1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same |
| 04/17/2003 | CA2461145A1 Live attenuated salmonella strains for producing vaccines |
| 04/17/2003 | CA2460625A1 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |